S336-0556 Screening compound: N-(4-chlorophenyl)-2-{3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetamide

S336-0556 Screening compound: N-(4-chlorophenyl)-2-{3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetamide
S336-0556 Screening compound: N-(4-chlorophenyl)-2-{3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S336-0556
N-(4-chlorophenyl)-2-{3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S336-0556

Molecular Formula

C14H15ClN4O2 (C14 H15 ClN4 O2)

Compound Name

N-(4-chlorophenyl)-2-{3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetamide

IUPAC name

N-(4-chlorophenyl)-2-{3-oxo-2H3H5H6H7H8H-[124]triazolo[43-a]pyridin-2-yl}acetamide

SMILES

O=C(CN1N=C(CCCC2)N2C1=O)Nc(cc1)ccc1Cl

InChI

InChI=1S/C14H15ClN4O2/c15-10-4-6-11(7-5-10)16-13(20)9-19-14(21)18-8-2-1-3-12(18)17-19/h4-7H,1-3,8-9H2,(H,16,20)

InChI Key

GSIUGIDMLXPFBV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28998108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

306.75

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.342

Distribution Coefficient, logD

2.342

Water Solubility, LogSw

-3.26

Polar Surface Area

56.334

Acid Dissociation Constant (pKa)

11.35

Base Dissociation Constant (pKb)

-0.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

S336-0556 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with S336-0556 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S336-0556?
Check Price and Availability of S336-0556, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S336-0556 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S336-0556
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S336-0556
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S336-0556 available by request